M L Bryant

Summary

Publications

  1. pmc Antiviral L-nucleosides specific for hepatitis B virus infection
    M L Bryant
    Novirio Pharmaceuticals, Inc, Cambridge, Massachusetts 02140, USA
    Antimicrob Agents Chemother 45:229-35. 2001
  2. ncbi request reprint Anti-HBV specific beta-L-2'-deoxynucleosides
    M L Bryant
    Novirio Pharmaceuticals, Inc, 125 Cambridge Park Dr, Cambridge, Massachussetts 02476, USA
    Nucleosides Nucleotides Nucleic Acids 20:597-607. 2001
  3. ncbi request reprint Antiviral beta-L-nucleosides specific for hepatitis B virus infection
    D N Standring
    Novirio Pharmaceuticals, Cambridge, Mass, USA
    Antivir Chem Chemother 12:119-29. 2001

Detail Information

Publications3

  1. pmc Antiviral L-nucleosides specific for hepatitis B virus infection
    M L Bryant
    Novirio Pharmaceuticals, Inc, Cambridge, Massachusetts 02140, USA
    Antimicrob Agents Chemother 45:229-35. 2001
    ..These investigational drugs, used alone or in combination, are expected to offer new therapeutic options for patients with chronic HBV infection...
  2. ncbi request reprint Anti-HBV specific beta-L-2'-deoxynucleosides
    M L Bryant
    Novirio Pharmaceuticals, Inc, 125 Cambridge Park Dr, Cambridge, Massachussetts 02476, USA
    Nucleosides Nucleotides Nucleic Acids 20:597-607. 2001
    ..Plasma viremia is reduced up to 8 logs in a woodchuck model of chronic HBV infection. These investigational drugs, used alone or in combination, are expected to offer new therapeutic options for patients with chronic HBV infection...
  3. ncbi request reprint Antiviral beta-L-nucleosides specific for hepatitis B virus infection
    D N Standring
    Novirio Pharmaceuticals, Cambridge, Mass, USA
    Antivir Chem Chemother 12:119-29. 2001
    ..These compounds have the potential for use in combination therapy with the goal of achieving superior viral suppression and diminishing the onset of resistance...